Effect of Telmisartan on the post stroke cognitive decline: a randomized open label study

Trial Profile

Effect of Telmisartan on the post stroke cognitive decline: a randomized open label study

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 13 May 2016

At a glance

  • Drugs Telmisartan (Primary) ; Antihypertensives
  • Indications Cerebral infarction; Hypertension
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 16 Mar 2016 Status changed from not yet recruiting to discontinued.
    • 05 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top